The emphysema market is anticipated to grow steadily, fueled by a range of emerging therapies under development. Leading candidates like SAR447537 (Sanofi), Alvelestat (Mereo BioPharma), BEAM-302 ...
The pulmonary emphysema market is poised for steady growth driven by rising COPD prevalence, an aging global population, and greater diagnostic awareness. Advances in inhaled therapies, targeted ...
Please provide your email address to receive an email when new articles are posted on . More adults with low vs. high A Priori Diet Quality Scores had emphysema. One researcher said diet can play a ...
This study is led by Dr. Lianyong Han and Dr. Tobias Stoeger in Germany (Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, German Research ...
Researchers at Weill Cornell Medicine and New York-Presbyterian in New York have discovered that injecting mice with healthy pulmonary endothelial cells (ECs)—the cells that line the walls of blood ...
Tokyo, Japan - Chronic obstructive pulmonary disease (COPD) causes illness and death worldwide. It is characterized by destruction of the walls of tiny air sacs in the lungs, known as emphysema, and a ...
Using data from the population-based CARDIA Study, a group of researchers, including Dr. Cora E. “Beth” Lewis, Chair of the Department of Epidemiology in the School of Public Health at the University ...
Objectives There is a lack of knowledge about whether occupational exposures increase the risk of emphysema, especially in ...
Emphysema and chronic bronchitis are lung conditions that fall under the term chronic obstructive pulmonary disease, or COPD. Some of the symptoms are similar, such as shortness of breath and wheezing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback